Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This pharmaceutical grade compound demonstrates significant potential in metabolic research applications.
The mechanism of action involves simultaneous stimulation of both GIP and GLP-1 receptors, leading to enhanced glucose-dependent insulin secretion and reduced glucagon secretion. These properties make tirzepatide for sale particularly interesting for researchers studying type 2 diabetes and obesity-related metabolic disorders.
Our tirzepatide for sale is synthesized through advanced chemical processes to ensure 99% purity. The white powder formulation maintains excellent stability and is suitable for various research applications. Each batch undergoes rigorous quality control testing to verify identity, purity, and potency.
Important Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Researchers should handle all materials according to appropriate laboratory safety protocols.